Loading company…
Riskpilot
← Back to search
Sign in
Get full access
DR.DROPIN AS
AS
Active
Org 827784362
Sørkedalsveien 8A, 0369 Oslo
Economic activity was not specified by tax authority · NACE 0000
Est. 2021
0 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2023
NOK 0
EBITDA margin
—
-33% vs 2022
Equity ratio
100.0%
Financial strength
Net profit 2023
NOK -4K
+18% vs 2022
EBITDA — year on year
NOK millions
0M
0M
1M
1M
1M
0M
2021
0M
0%
2022
0M
0%
2023
Key figures
Annual report 2023
Revenue
NOK 0
—
EBITDA
NOK -7K
-33%
Net profit
NOK -4K
+18%
Total assets
NOK 20M
+5%
Equity
NOK 20M
+5%
Employees
0
—
Company information
Legal name
DR.DROPIN AS
Org number
827784362
Legal form
Aksjeselskap
NACE code
0000 · Economic activity was not specified by tax authority
Founded
22. september 2021
Share capital
NOK 159 686
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Company purpose
Investere i og å rådgi ulike selskaper.
Contact
Address
Sørkedalsveien 8A, 0369 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Economic activity was not specified by tax authority
Companies in Oslo
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
Income statement
NOK thousands
Item
2021
2022
2023
Revenue
0
0
0
Staff expenses
−0
−0
−0
EBITDA
−6
−5
−7
Depreciation & amort.
−0
−0
−0
EBIT
−6
−5
−7
Net financials
0
0
3
Profit before tax
−6
−5
−4
Tax
−0
−0
−0
Net profit
−6
−5
−4
Balance sheet
NOK thousands
Item
2021
2022
2023
Total assets
24
19 135
20 027
Equity
24
19 135
20 027
Long-term debt
0
0
0
Short-term debt
0
0
0
Total debt
0
0
0
Financial ratios
5-year trend
EBITDA margin
-668900.0%
This company
15.8%
Market median
-4233644% vs market
2021
2023
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
2021
2023
Return on equity
-0.0%
This company
18.4%
Market median
-100% vs market
2021
2023
Net profit margin
-402300.0%
This company
8.1%
Market median
-4966767% vs market
2021
2023
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2021
2023
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
2021
2023
Annual reports & filings
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Age
Other directorships
HL
Håvard Liltved Dalen
Chairman
2022
—
—
ML
Martin Lycke
Chairman
2021
—
—
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Raan Holding As
Company
18.8%
18.8%
2022
Bamsic As
Company
14.2%
14.2%
2022
Berry As
Company
13.0%
13.0%
2022
Dr.Dropin As
Company
11.8%
11.8%
2022
Ledang Health As
Company
10.9%
10.9%
2022
Doktor Feldborg As
Company
7.1%
7.1%
2022
Proventure Seed Iii As
Company
4.9%
4.9%
2022
Etud Ab
Company
4.2%
4.2%
2022
Christiania Ferjedrift As
Company
3.4%
3.4%
2022
Citron As
Company
3.3%
3.3%
2022
Ymir Labs As
Company
2.7%
2.7%
2022
Norkri Holding As
Company
2.2%
2.2%
2022
Dørte Koss Harnes
Individual
1.6%
1.6%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Ledang Health As
DR.DROPIN AS
(this company)
DR.DROPIN SPESIALIST AS
Board network connections
Board members of DR.DROPIN AS also hold positions in
0
other companies.
Person
Role here
Other companies
Håvard Liltved Dalen
Chairman
0 companies
Martin Lycke
Chairman
0 companies